The Venture Codex Logo

The Venture Codex

CureDuchenne Ventures

100 Bayview Circle, Ste 5600, Newport Beach, CA, 92660, United States

Overview

Private equity firm focused on investment opportunities.

Founded

2014

Deals · 12mo

0

Links

WebsiteLinkedIn

Stage focus

Seed
Series A
Series B

Geographic focus

Canada
United Kingdom
United States

Sector focus

—

Investment portfolio

16rounds
NAMEDATESIZE
Entos Pharmaceuticals
May 2025Led
$1 MOther Equity
Myosana Therapeutics
Jan 2023Participated
$5 MSeed
Code Biotherapeutics
Jun 2022Participated
$75 MSeries A
Pepgen
Aug 2021Participated
$113 MOther Equity
Code Biotherapeutics
Apr 2021Participated
$10 MSeed
Entrada Therapeutics
Mar 2021Participated
$116 MSeries B
Pepgen
Dec 2020Participated
$45 MSeries A
Edgewise Therapeutics
Dec 2020Participated
$95 MSeries C
Myosana Therapeutics
Apr 2020Led
$1 MSeed
Avidity Biosciences
Nov 2019Participated
$100 MSeries C
Shape Therapeutics
Nov 2019Participated
$36 MSeries A
Edgewise Therapeutics
Sep 2019Participated
$50 MSeries B
Entos Pharmaceuticals
May 2025Led
$1 MOther Equity
Myosana Therapeutics
Jan 2023Participated
$5 MSeed
Code Biotherapeutics
Jun 2022Participated
$75 MSeries A
Pepgen
Aug 2021Participated
$113 MOther Equity
Code Biotherapeutics
Apr 2021Participated
$10 MSeed
Entrada Therapeutics
Mar 2021Participated
$116 MSeries B
Pepgen
Dec 2020Participated
$45 MSeries A
Edgewise Therapeutics
Dec 2020Participated
$95 MSeries C
Myosana Therapeutics
Apr 2020Led
$1 MSeed
Avidity Biosciences
Nov 2019Participated
$100 MSeries C
Shape Therapeutics
Nov 2019Participated
$36 MSeries A
Edgewise Therapeutics
Sep 2019Participated
$50 MSeries B
16
Items
...
Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

CureDuchenne Ventures: 16 funding rounds are recorded in the selected participation categories.All available history.
CureDuchenne Ventures: 16 funding rounds are recorded in the selected participation categories. All available history
Round typeLed dealsParticipated deals
Seed22
Series A03
Series B03
Series C+02
Other Equity31

Monthly Deal Activity

CureDuchenne Ventures: 16 deals are recorded across 142 months.All available history.
CureDuchenne Ventures: 16 deals are recorded across 142 months. All available history
MonthDeals
Jan '151
Feb '150
Mar '150
Apr '150
May '150
Jun '150
Jul '150
Aug '150
Sep '151
Oct '150
Nov '150
Dec '150
Jan '160
Feb '160
Mar '160
Apr '160
May '160
Jun '160
Jul '160
Aug '160
Sep '160
Oct '160
Nov '160
Dec '160
Jan '170
Feb '171
Mar '170
Apr '170
May '170
Jun '170
Jul '170
Aug '170
Sep '170
Oct '170
Nov '170
Dec '170
Jan '180
Feb '180
Mar '180
Apr '180
May '180
Jun '180
Jul '180
Aug '180
Sep '181
Oct '180
Nov '180
Dec '180
Jan '190
Feb '190
Mar '190
Apr '190
May '190
Jun '190
Jul '190
Aug '190
Sep '191
Oct '190
Nov '192
Dec '190
Jan '200
Feb '200
Mar '200
Apr '201
May '200
Jun '200
Jul '200
Aug '200
Sep '200
Oct '200
Nov '200
Dec '202
Jan '210
Feb '210
Mar '211
Apr '211
May '210
Jun '210
Jul '210
Aug '211
Sep '210
Oct '210
Nov '210
Dec '210
Jan '220
Feb '220
Mar '220
Apr '220
May '220
Jun '221
Jul '220
Aug '220
Sep '220
Oct '220
Nov '220
Dec '220
Jan '231
Feb '230
Mar '230
Apr '230
May '230
Jun '230
Jul '230
Aug '230
Sep '230
Oct '230
Nov '230
Dec '230
Jan '240
Feb '240
Mar '240
Apr '240
May '240
Jun '240
Jul '240
Aug '240
Sep '240
Oct '240
Nov '240
Dec '240
Jan '250
Feb '250
Mar '250
Apr '250
May '251
Jun '250
Jul '250
Aug '250
Sep '250
Oct '250
Nov '250
Dec '250
Jan '260
Feb '260
Mar '260
Apr '260
May '260
Jun '260
Jul '260
Aug '260
Sep '260
Oct '260

Sector Breakdown

CureDuchenne Ventures: Health & Life Sciences is the largest displayed sector by deal count (16 deals).All available history.

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

CureDuchenne Ventures: Health & Life Sciences is the largest displayed sector by deal count (16 deals). All available history
SectorDeals
Health & Life Sciences16

Deal Size Distribution

CureDuchenne Ventures: 16 rounds have a disclosed size in the displayed size bands.All available history.

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

CureDuchenne Ventures: 16 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)Deals
<$5M4
$5M-$10M2
$10M-$25M1
$25M-$50M2
$50M-$100M4
$100M-$250M3
$250M-$500M0
$500M-$1B0
$1B+0

Deals By Geography

CureDuchenne Ventures: United States has the largest recorded deal count among the displayed regions (13 deals).All available history.

Top 3 of 3 regions; European countries are grouped as Europe.

CureDuchenne Ventures: United States has the largest recorded deal count among the displayed regions (13 deals). All available history
RegionDeals
United States13
Europe2
Canada1
CureDuchenne Ventures: 20 co-investors are shown, with Deerfield Management sharing 3 recorded deals.All available history.

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

CureDuchenne Ventures: 20 co-investors are shown, with Deerfield Management sharing 3 recorded deals. All available history
Co-investorShared deals
Deerfield Management3
New Enterprise Associates3
RA Capital Management3
Takeda Ventures3
Viking Global Investors3
4BIO Capital2
Cormorant Asset Management2
Janus Henderson Investors2
JDRF T1D Fund2
Logos Capital2
Novo Holdings2
OrbiMed2
Oxford Science Enterprises2
Perceptive Advisors2
U.S. Venture Partners2
UPMC Enterprises2
Wellington Management2
5AM Ventures1
Adage Capital Management1
Agent Capital1

Investment Strategy

CureDuchenne Ventures: Led accounts for 31% and participating for 69% of round participation.All available history.
CureDuchenne Ventures: Led accounts for 31% and participating for 69% of round participation. All available history
CategoryDeals (count)Share (%)
Led531%
Participating1169%
CureDuchenne Ventures: Single-lead accounts for 100% and co-led for 0% of lead dynamics.All available history.
CureDuchenne Ventures: Single-lead accounts for 100% and co-led for 0% of lead dynamics. All available history
CategoryDeals (count)Share (%)
Single-lead5100%
Co-led00%

Team

Bradley L Hodges

Partner

Debra Miller

CEO